Published in Law and Health Weekly, July 16th, 2005
The data was presented at the 7th World Congress on Gastrointestinal Cancer in Barcelona, Spain.
The study, coauthored by Nigel C. Phillips, chief scientific officer and Mario C. Filion, Head of Biomedical Research at Bioniche Life Sciences, Inc., evaluated the in vitro activity of MCC against DHD/K12/PROb cells, and the in vivo activity of MCC against DHD/K12/PROb peritoneal carcinomatosis in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.